| Active substance | Eltrombopag |
| Holder | Novartis |
| Status | Closed |
| Indication | Thrombocytopenia in patients with severe aplastic anemia |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 01/03/2017 |
Revolade®
Last updated on 13/09/2024